Drug Approval | May 10, 2024
Cipla receives 1 observation from USFDA for Kurkumbh facility
The company is committed to address this observation comprehensively within stipulated time
The company is committed to address this observation comprehensively within stipulated time
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
At least one recognised startup in every State and UT; spread across over 80% of districts
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
The plant is yet to start commercial operations
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Subscribe To Our Newsletter & Stay Updated
